Mutual Fund Details

Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment

Name: Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment
Brand: Aditya Birla Sun Life Mutual Fund

Equity Pharma

NAV

₹23.5000

as on 20 Dec 2024, 11:48 PM

₹-0.2000(0.84%)

Last Change

Scheme Ratings

rated by Value Research

Pharma

Rankings based on | as on Invalid date

Schemes Managed By

Dhaval Shah

Fund Manager

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,70,904

₹1,78,425

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹78,425

Profit (absolute return)

78.43%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

1.91%

In the last 6 months

15.53%

In the last 1 year

39.48%

In the last 3 years

78.43%

In the last 5 years

219.76%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment

as of 30 Nov 2024, 05:30 AM

₹854.32 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 30 days.

0.93%

Expense Ratio

Plan

Dividend

2.18%

Cash Holding

Benchmark

BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 30 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

95.14%

₹812.83 Cr

Services

1.82%

₹15.59 Cr

Chemicals

0.85%

₹7.27 Cr

Others

2.18%

₹18.62 Cr

Sectors Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Sector

Healthcare

95.14%

₹812.83 Cr

Services

1.82%

₹15.59 Cr

Chemicals

0.85%

₹7.27 Cr

Others

2.18%

₹18.62 Cr

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.63%

₹124.99 Cr

Cipla Ltd.

8.72%

₹74.50 Cr

Torrent Pharmaceuticals Ltd.

7.62%

₹65.10 Cr

Apollo Hospitals Enterprise Ltd.

6.41%

₹54.76 Cr

Aurobindo Pharma Ltd.

5.78%

₹49.38 Cr

Others

56.84%

₹485.60 Cr

View All

Companies Holding in this Mutual Fund

as on 30 Nov 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.63%

₹124.99 Cr

Cipla Ltd.

8.72%

₹74.50 Cr

Torrent Pharmaceuticals Ltd.

7.62%

₹65.10 Cr

Apollo Hospitals Enterprise Ltd.

6.41%

₹54.76 Cr

Aurobindo Pharma Ltd.

5.78%

₹49.38 Cr

Others

56.84%

₹485.60 Cr

View All

Funds in this Category

This fund's returns:

21.27%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

DSP Healthcare Fund Direct - Growth

About Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment

Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment is a Equity mutual fund scheme from Aditya Birla Sun Life Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Dhaval Shah. It has an AUM of ₹854.32 Crores and the latest NAV decalared is ₹23.500 as on 23 Dec 2024 at 3:18 am.

Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment scheme return performance in last 1 year is 39.48%, in last 3 years is 78.43% and 238.07% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.